Howard C. Herrmann, MD
Howard C. Herrmann, MD
Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine
Contact information
HUP - 9 Gates
3400 Spruce Street
4283
Philadelphia, PA 19104
3400 Spruce Street
4283
Philadelphia, PA 19104
Office: (215) 662-2180
Fax: (215 349-5894
Fax: (215 349-5894
Publications
Education:
A.B. (Biochemistry)
Harvard College, 1977.
M.D. (Physiology)
Harvard Medical School, 1981.
Permanent linkA.B. (Biochemistry)
Harvard College, 1977.
M.D. (Physiology)
Harvard Medical School, 1981.
Description of Research Expertise
clinical trials, new devices and drugs in interventional cardiologyDescription of Clinical Expertise
coronary artery disease, valvular heart disease, coronary stents, cardiac catheterization, mitral valve disease, aortic valve disease, hypertrophic obstructive cardiomyopathy, atrial septal defects, patent foramen ovaleSelected Publications
Kelley MP, Klugherz BD, Hashemi SM, Meneveau NF, Johnston JM, Matthai WH, Banka VS, Herrmann HC, et al: One-Year Clinical Outcomes of Protected and Unprotected Left Main Coronary Artery Stenting. European Heart Journal 2004 Notes: in press.Valettas N, Rho R, Beshai R, Lloyd CT, Ross HT, Kocovic D, Herrmann HC: Alcohol Septal Ablation Complicated by Complete Heart Block and Permanent Pacemaker Failure. Cath Cardiovasc Interven 58: 189-193, 2003.
Schneider DJ, Herrmann HC, Lakkis N, Aguirre F, Lo MW, Yin, KC, Aggarwal A, Kabbani SS, DiBattiste PM: Increased Concentrations of Tirofiban in Blood and Their Correlation with Inhibition of Platelet Aggregation After Greater Bolus Doses of Tirofiban. Am J Card 91: 334-336, 2003.
Maisel AS, McCord J, Nowak RM,…Herrmann HC, McCullough PA: Bedside B-type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure With Reduced or Preserved Ejection Fraction: Results From the Breathing Not Properly (BNP) Multinational Study. J Am Coll Cardiol 41: 2010-2017, 2003.
Kereiakes DJ, Szyniszewski AM, Herrmann HC, Simon DI, Rogers C, Kramer P, et al: A Phase ! Drug and Light Dose-Escalation Trial of Motexafin Lutetium Injection and Far Red Light Activation (Photo Angioplasty) in Subjects with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention and Stent Deployment: Procedural and Long-Term Results. Circulation 2003 Notes: submitted.
Maisel AS, Clopton P, Krishnaswamy P,…Herrmann HC, Aumont MC, McCullough PA: The Impact of Age, Race and Gender on the Ability of BNP to Aid in the Emergency Diagnosis of Heart Failure: Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol 2003 Notes: submitted.
Stone GW, Rogers C, Hermiller J, Feldman R, Hall P, Haber R, Masud A, Cambier P, Caputo R, Turco BM, Kovach R, Brodie B, Herrmann HC, Kuntz RE, Popma JJ, Ramee S, Cox DA: Randomized Comparison of Distal Protection with a Filter-Based Catheter and a Balloon Occlusion and Aspiration System During Percutaneous Intervention of Diseased Saphenous Vein Aorto-Coronary Bypass Grafts. Circulation 2003 Notes: submitted.
Ellis S, et al. Facilitated Percutaneous Coronary Intervention Versus Primary PCI: The FINESSE (Facilitated Intervention With Enhanced Reperfusion Speed to Stop Events) Trial: Design and Rationale. Am Heart J 2003 Notes: submitted.
Ellis SG, Armstrong P, Bertriu A, Brodie B, Herrmann HC, Montalscot G, Neumann FJ, Smith JJ, Topol EJ: Facilitated Percutaneous Coronary Intervention Versus Primary PCI: The FINESSE Trial. Am Heart J 2003 Notes: submitted.
Herrmann HC: Aspirin Resistance Predicts Adverse Cardiovascular Events. Journal Watch for Cardiology (eds.). Mass. Medical Society, Waltham, MA, 9: 50, 2003.
| Protocol | Title | Status |
|---|---|---|
| 800840 | JOSTENT GraftMaster Coronary Stent Graft Emergent Use for Coronary Artery Free Perforations | Unknown |
| 805465 | ACCESS PFO Registry: Patent Foramen Ovale Closure with the AMPLATZER PFO OCCULDER in Patients with REcurrent Cryptogenic Stroke due to Presumed Paradoxical EmboliSm through a Patent Foramen Ovale who have Failed Conventional Drug Therapy (AGA-011, Revision B, Dated 21-Sep-2006) | Recruiting |
| 802610 | EVEREST II: A Study of the Evalve Cardiovascular Valve Repair System (CVRS) Endovascular Valve Edge-to-Edge Repair Study | Recruiting |